The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Singer David B since 2006.
The trader's CIK number is 1240366.
At the time of the last reporting, Singer David B was the Director of Oscient Pharmaceuticals Corp. (stock ticker symbol OSCI).
Also see all insider trading activities at Oscient Pharmaceuticals Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | OSCI | 0 | $0 | 261,096 | $340,660 | 261,096 | $18,271 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-06-07 | OSCI | Option Ex | 24,013 | .07 | 1,680 |
| 2006-06-08 | OSCI | Option Ex | 12,083 | .07 | 845 |
| 2006-06-07 | OSCI | Sale | 24,013 | 1.22 | 29,223 |
| 2006-06-08 | OSCI | Sale | 12,083 | 1.23 | 14,801 |
| 2006-06-02 | OSCI | Sale | 39,798 | 1.25 | 49,946 |
| 2006-06-01 | OSCI | Sale | 5,217 | 1.27 | 6,651 |
| 2006-06-02 | OSCI | Option Ex | 39,798 | .07 | 2,785 |
| 2006-06-01 | OSCI | Option Ex | 5,217 | .07 | 365 |
| 2006-05-26 | OSCI | Option Ex | 34,042 | .07 | 2,382 |
| 2006-05-26 | OSCI | Sale | 34,042 | 1.32 | 44,833 |
| 2006-05-30 | OSCI | Option Ex | 4,785 | .07 | 334 |
| 2006-05-31 | OSCI | Option Ex | 5,200 | .07 | 364 |
| 2006-05-30 | OSCI | Sale | 4,785 | 1.30 | 6,244 |
| 2006-05-31 | OSCI | Sale | 5,200 | 1.30 | 6,760 |
| 2006-05-25 | OSCI | Sale | 73,958 | 1.32 | 97,994 |
| 2006-05-25 | OSCI | Option Ex | 73,958 | .07 | 5,177 |
| 2006-05-23 | OSCI | Option Ex | 25,463 | .07 | 1,782 |
| 2006-05-22 | OSCI | Sale | 36,537 | 1.35 | 49,324 |
| 2006-05-23 | OSCI | Sale | 25,463 | 1.37 | 34,884 |
| 2006-05-22 | OSCI | Option Ex | 36,537 | .07 | 2,557 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Singer David B (Director of Oscient Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.